Urinary Incontinence, Quality of Life, and Risk Factors in a Geriatric Cohort.


Journal

Urologia internationalis
ISSN: 1423-0399
Titre abrégé: Urol Int
Pays: Switzerland
ID NLM: 0417373

Informations de publication

Date de publication:
2023
Historique:
received: 20 02 2023
accepted: 12 06 2023
medline: 3 11 2023
pubmed: 24 8 2023
entrez: 23 8 2023
Statut: ppublish

Résumé

The aim of the study was to evaluate the prevalence of urinary incontinence (UI) and its subtypes, associated clinical factors, and impact on quality of life (QoL) in a geriatric population aged 80 years or older. Male and female residents (inclusion criterion: 80 years or older) of three Viennese senior citizen homes were personally interviewed with the aid of a structured questionnaire based on the Bristol Female Lower Urinary Tract Symptom Questionnaire within a 12-month period. UI was defined as any involuntary loss of urine during the past 4 weeks. Several demographic parameters were obtained additionally. 434 participants with a mean age of 86.8 years (women: 87.6 years; men: 86.1 years) were included. UI was present in 52.5% (57% female vs. 23% male, p < 0.001), stress UI affected 36% (41% female vs. 5% male, p < 0.001), urge UI 38% (40.5% female vs. 23% male, p < 0.01), and mixed UI 28% (24% female vs. 5.0% male, p < 0.01). While the overall prevalence of UI remained rather stable in the four age cohorts (80-84 years, 85-89 years, 90-94 years, >94 years), there was a constant decline of SUI paralleled by an increase of UI and - to a lesser extent - of MUI with age. 36.5% (33% female vs. 57% male) participants did not report any negative impact on QoL, while a severe reduction of QoL was present in 31% of cases (35% female vs. 10.0% male). Risk factors for UI and its subtypes included female sex, reduced/no mobility, hysterectomy, and number of births. This study provides data on the high prevalence of UI in a low-morbid geriatric cohort and evaluates gender-specific differences in UI prevalence, associated risk factors, and QoL.

Identifiants

pubmed: 37611548
pii: 000531582
doi: 10.1159/000531582
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

866-871

Informations de copyright

© 2023 S. Karger AG, Basel.

Auteurs

Klaus Eredics (K)

Department of Urology, Clinic Donaustadt, Vienna, Austria.
Department of Urology, Paracelsus Medical University, Salzburg, Austria.

Clemens Wehrberger (C)

Department of Urology, Clinic Donaustadt, Vienna, Austria.

Leo Edlinger (L)

Department of Internal Medicine/Division of Oncology, Medical University of Graz, Graz, Austria.

Ulrik Müller (U)

Department of Urology, Landesklinikum Thermenregion, Baden, Austria.

Michael Rauchenwald (M)

Department of Urology, Clinic Donaustadt, Vienna, Austria.

Marlies Wehrberger (M)

Department of Urology, Clinic Donaustadt, Vienna, Austria.

Stephan Madersbacher (S)

Department of Urology, Clinic Favoriten and Sigmund Freud Private University, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH